Jefferson Public Radio3h
A small seafood restaurant turns into a national donation hub for LA fire victims
In response to the devastating fires raging in LA, a small restaurant in Surf City USA has become a channel for big help — ...
Tex-Mex brunch restaurant ‘Calico Cactus’ to open in St. Augustine
Queso, coffee and tacos combine at Calico Cactus, officially opening its doors in St. Augustine this month. The restaurant ...
ALS drugs from Denali, Calico come up short, marking setback for Healey trial
Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...
Southern California businesses offering to help fire victims
Here is a list of some of the businesses offering support. KCAL has partnered with the American Red Cross to help those ...
STAT1d
Pharma’s big patent cliff, more obesity fundraising, and a failed ALS study
STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.
BioSpace16h
HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...
STAT3d
Google’s secretive anti-aging company Calico finally released data. Its drug failed
The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is ...
Financial News & Daily Record1d
Calico Cactus to open Jan. 14 in St. Augustine
The grand opening of Scott Moore’s new venture, Calico Cactus, A Modern Taco Shop, in St. Augustine, is schedule for Jan. 14.
FierceBiotech3d
Rival AbbVie and Denali prospects flunk phase 2/3 ALS tests, denting hopes for shared mechanism
AbbVie, Calico and Denali Therapeutics’ hopes of treating amyotrophic lateral sclerosis (ALS) by targeting eIF2B have all ...
Crain's Chicago Business2d
AbbVie and rival's ALS drugs both disappoint in study
In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...